Niraj Bhalani, DO
Internal Medicine · Templeton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 8 years
- Graduated 2018
Offices
2 locations · Pacific Central Coast Health Centers · Community Foundation Medical Group
Hospitals listed: Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhalani’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A17979 · Deceased
Licence status: Deceased · since 1958 · University of Southern California Keck School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$12,075
Medicare paid this office $12,075 for 60 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 31 | $2,754 | $89 |
| New patient visit (45+ min) | 16 | $2,018 | $126 |
| Short return visit (20+ min) | 23 | $1,919 | $74 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $870 | $79 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $810 | $74 |
Procedures Medicare counted
| Colonoscopy | 109 | More than 82% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 91 | More than 75% of doctors who do this |
Who their Medicare patients are
60 Original Medicare patients in 2024. Average age 69 · Under 65 25% · Women 68% · Also on Medicaid 45% · Health risk score 1.35. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 35% · Depression 23% · Coronary heart disease 22% · Heart failure 20% · Chronic kidney disease 20%.
The office billed $74,599, Medicare allowed $15,220 and paid $12,075; for 123 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$12,050 in 2024
Medicaid paid $12,050 for 478 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 66 | $12,050 |
| TOBACCO NON-USER | 80 | $0 |
| BODY MASS INDEX DOCD | 84 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 52 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 52 | $0 |
| Screening for depression performed (DEM) | 70 | $0 |
| Short return visit (20+ min) | 54 | $0 |
| Return visit (30+ min) | 20 | $0 |
| 2024 | 478 | 8 | 30 | $12,050 |
Drugs they prescribed that Part D paid
$84,363
Pharmacies billed $84,363 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 84) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
65 generic and 19 brand-name prescriptions · $84,363 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 14 | $834 | $60 |
| Gavilyte-G | 28 | $397 | $14 |
| Pantoprazole | 13 | $93 | $7 |
Money from drug and device companies
$441 in 2025
| 2025 | 8 | 27 | None | $441 |
| 2024 | 4 | 8 | None | $261 |
| 2023 | 2 | 6 | None | $140 |
| 2022 | 2 | 3 | None | $123 |
| 2021 | 2 | 3 | None | $239 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $199 | 14 payments
|
| Gilead Sciences | None | $66 | 3 payments
|
| Ardelyx | Ibsrela | $51 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $51 | 3 payments
|
| Janssen Biotech | Tremfya | $29 | 1 payment
|
| Organon | Hadlima | $17 | 1 payment
|
See all 27 published payments
| Abbvie | Meals · 2025-12-12 | Mavyret | $11 |
| Gilead Sciences | Meals · 2025-10-31 | None | $18 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $19 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $1 |
| Ardelyx | Meals · 2025-09-26 | Ibsrela | $18 |
| Aimmune Therapeutics | Meals · 2025-09-26 | Zenpep | $14 |
| Janssen Biotech | Meals · 2025-09-25 | Tremfya | $29 |
| Abbvie | Meals · 2025-09-09 | Linzess | $10 |
| Medtronic | Meals · 2025-09-05 | Pillcam | $14 |
| Ardelyx | Meals · 2025-09-04 | Ibsrela | $14 |
| Aimmune Therapeutics | Meals · 2025-08-12 | Vowst | $21 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $22 |
| Aimmune Therapeutics | Meals · 2025-07-17 | Zenpep | $16 |
| Abbvie | Meals · 2025-07-11 | Linzess | $8 |
| Gilead Sciences | Meals · 2025-07-10 | None | $21 |
| Gilead Sciences | Meals · 2025-06-09 | None | $27 |
| Abbvie | Meals · 2025-06-05 | Rinvoq | $22 |
| Abbvie | Meals · 2025-05-26 | Rinvoq | $2 |
| Abbvie | Meals · 2025-05-26 | Rinvoq | $15 |
| Organon | Meals · 2025-05-22 | Hadlima | $17 |
| Abbvie | Meals · 2025-04-18 | Linzess | $13 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-17 | Entyvio | $15 |
| Abbvie | Meals · 2025-03-17 | Rinvoq | $25 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $25 |
| Abbvie | Meals · 2025-01-23 | Rinvoq | $26 |
| Abbvie | Meals · 2025-01-23 | Skyrizi | $1 |
| Ardelyx | Meals · 2025-01-22 | Ibsrela | $19 |
See earlier years (2024, 2023, 2022, 2021)
2024: $261
| Phathom Pharmaceuticals | Voquezna | $125 | 1 payment
|
| Abbvie | Rinvoq | $95 | 5 payments
|
| Ironwood Pharmaceuticals | Linzess | $21 | 1 payment
|
| RedHill Biopharma | Talicia | $21 | 1 payment
|
2023: $140
| AbbVie | Rinvoq | $120 | 5 payments
|
| Ardelyx | Ibsrela | $20 | 1 payment
|
2022: $123
| Abbvie | Creon | $104 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $19 | 1 payment
|
2021: $239
| AbbVie | None | $124 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $115 | 2 payments
|
Professional record
- NPI
- 1255838363
- Licence
- CA 17979California A17979: Deceased
- Group
- Pacific Central Coast Health Centers · Community Foundation Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 350 Posada Ln Ste 202, Templeton, CA, 93465
- NPI first listed
- 2018-04-06
- NPI last updated
- 2026-03-17
- NPI record certified
- 2026-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 850 Fair Oaks Ave Ste 220, Arroyo Grande, CA, 93420 · 155 N Fresno St, Fresno, CA, 93701 · 1551 Bishop St Ste 230, San Luis Obispo, CA, 93401